Two Sigma Investments, LP Avrobio, Inc. Transaction History

Two Sigma Investments, LP

$40.3 Billion
Q1 2024

A detailed history of Two Sigma Investments, LP transactions in Avrobio, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 270,452 shares of AVRO stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

270,452

Previous 309,516 12.62%

Holding current value

Previous $420,000 17.62%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.15 - $1.48 $44,923 - $57,814	-39,064 Reduced 12.62%	270,452 $346,000
Q4 2023 Feb 14, 2024	SELL	$1.22 - $1.62 $22,446 - $29,806	-18,399 Reduced 5.61%	309,516 $420,000
Q3 2023 Nov 14, 2023	BUY	$0.98 - $1.62 $41,212 - $68,127	42,054 Added 14.71%	327,915 $504,000
Q2 2023 Aug 14, 2023	SELL	$0.58 - $1.31 $27,339 - $61,749	-47,137 Reduced 14.16%	285,861 $271,000
Q1 2023 May 15, 2023	BUY	$0.76 - $1.82 $11,511 - $27,567	15,147 Added 4.77%	332,998 $332,000

Q4 2022 Feb 14, 2023	SELL	$0.64 - $0.91 $47,854 - $68,043	-74,773 Reduced 19.04%	317,851 $225,000
Q3 2022 Nov 14, 2022	SELL	$0.68 - $1.11 $55,093 - $89,932	-81,020 Reduced 17.11%	392,624 $252,000
Q2 2022 Aug 15, 2022	SELL	$0.75 - $1.33 $149,091 - $264,389	-198,789 Reduced 29.56%	473,644 $436,000
Q1 2022 May 16, 2022	BUY	$1.29 - $4.04 $258,643 - $810,015	200,499 Added 42.48%	672,433 $888,000
Q4 2021 Feb 14, 2022	BUY	$3.45 - $6.05 $499,166 - $875,350	144,686 Added 44.21%	471,934 $1.82 Million
Q3 2021 Nov 15, 2021	BUY	$5.53 - $9.28 $1.14 Million - $1.91 Million	205,800 Added 169.46%	327,248 $1.83 Million
Q2 2021 Aug 16, 2021	BUY	$7.84 - $12.6 $12,363 - $19,870	1,577 Added 1.32%	121,448 $1.08 Million
Q1 2021 May 17, 2021	BUY	$10.54 - $19.3 $279,215 - $511,276	26,491 Added 28.37%	119,871 $1.52 Million
Q4 2020 Feb 16, 2021	BUY	$12.79 - $17.1 $1.03 Million - $1.38 Million	80,438 Added 621.53%	93,380 $1.3 Million
Q3 2020 Nov 16, 2020	SELL	$12.99 - $19.41 $687,443 - $1.03 Million	-52,921 Reduced 80.35%	12,942 $169,000
Q2 2020 Aug 14, 2020	BUY	$12.19 - $22.96 $802,869 - $1.51 Million	65,863 New	65,863 $1.15 Million
Q1 2020 May 15, 2020	SELL	$10.08 - $27.21 $378,010 - $1.02 Million	-37,501 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$13.05 - $21.88 $489,388 - $820,521	37,501 New	37,501 $755,000

Others Institutions Holding AVRO

# of Institutions

Shares Held

28.1M

Call Options Held

Put Options Held

100

View Full List

About AVROBIO, Inc.

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

More about AVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Avrobio, Inc. Transaction History